Genetics and Health Care: A Paradigm Shift

This article is about health care in the future—some of the things addressed are quite a few years in the future, some are here now, and others are coming very fast. I want to put my remarks in the context of my conviction that as a society we need to change our view of disease as an outside enemy—and find a new way of thinking about illness. Over the last century or so, the living conditions of human populations in developed countries have altered markedly, with resulting dramatic changes in health, largely owing to progress in nutrition and hygiene. Measures of population health such as life expectancy rose rapidly in the early decades of this century, with far fewer people dying prematurely from malnutrition or infectious diseases such as TB and cholera. A larger proportion ofthe population now lives to approach the normal biological life span of humans, which is probably in the 85-95year range [I]. The age structure of the population has changed from one that has a preponderance of young people under 30 to a distribution that includes more people in their middle years and older. The benefits of public health and good nutrition in Western societies have led to a remarkable decrease in those diseases with a primarily external cause. Perhaps because of this success, most physicians and investigators have perceived that deleterious influences on human health are of two kinds: either a deficiency of a basic resource such as food or vitamins, or exposure to hazards that may be either natural (such as parasites, bacteria, or viruses) or man-made (such as smoking, war, environmental pollutants [2]). Genetics is now showing that this view of the determinants ofhealth as being external is too simplistic. It neglects a major determinant of disease—an internal one. Far from being a rare cause of disease, genetic The author expresses gratitude for helpful comments and criticism to J. Friedman and

[1]  N. Holtzman Feature article: Recombinant DNA technology, genetic tests, and public policy. , 1988, American journal of human genetics.

[2]  M. Leppert,et al.  A DNA probe for the LDL receptor gene is tightly linked to hypercholesterolemia in a pedigree with early coronary disease. , 1986, American journal of human genetics.

[3]  M. Hayden,et al.  Characterization of six partial deletions in the low-density-lipoprotein (LDL) receptor gene causing familial hypercholesterolemia (FH). , 1988, American journal of human genetics.

[4]  H. Pétursson,et al.  Molecular genetic evidence for heterogeneity in manic depression , 1987, Nature.

[5]  D. Pollen,et al.  The genetic defect causing familial Alzheimer's disease maps on chromosome 21. , 1987, Science.

[6]  C. Scriver,et al.  An evolutionary view of disease in man , 1984 .

[7]  Kurata Jh,et al.  Epidemiology of peptic ulcer disease. , 1984, Clinics in gastroenterology.

[8]  J. Lalouel,et al.  Chromosome mapping with DNA markers. , 1988, Scientific American.

[9]  H B Newcombe,et al.  Genetic disorders in children and young adults: a population study. , 1988, American journal of human genetics.

[10]  M. Skolnick,et al.  Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. , 1988, The New England journal of medicine.

[11]  H. Ostrer,et al.  Prenatal diagnosis and carrier detection of genetic diseases by analysis of deoxyribonucleic acid. , 1988, The Journal of pediatrics.

[12]  J F Fries,et al.  Aging, natural death, and the compression of morbidity. , 1980, The New England journal of medicine.

[13]  F. Vogel,et al.  Human Genetics: Problems and Approaches , 1979 .

[14]  Scriver Cr The William Allan Memorial Award address: On phosphate transport and genetic screening. "Understanding backward--living forward" in human genetics. , 1979 .

[15]  M. Hetzel,et al.  Metabolic oxidation phenotypes as markers for susceptibility to lung cancer , 1984, Nature.

[16]  R. Weinberg,et al.  Oncogenes and tumor-suppressing genes. , 1988, The New England journal of medicine.

[17]  Malcolm C. Brown Caring for Profit: Economic Dimensions of Canada's Health Industry , 1987 .

[18]  J. Rotter,et al.  Genetics and heterogeneity of common gastrointestinal disorders , 1980 .

[19]  K. Davies,et al.  A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16 , 1985, Nature.

[20]  M. Kaback Medical genetics: an overview. , 1978, Pediatric clinics of North America.

[21]  G. Boers,et al.  Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. , 1985, The New England journal of medicine.

[22]  L. Thomas The technology of medicine. , 1971, The New England journal of medicine.

[23]  T McKeown,et al.  A basis for health strategies. A classification of disease. , 1983, British medical journal.

[24]  Scriver Cr,et al.  On the heritability of rickets, a common disease (Mendel, mammals and phosphate). , 1981 .

[25]  V. McKusick Mendelian inheritance in man , 1971 .

[26]  L. S. King,et al.  Medical Thinking: A Historical Preface , 1982 .

[27]  J. Rotter,et al.  Measuring the genetic contribution of a single locus to a multilocus disease , 1984, Clinical genetics.

[28]  K. Kidd,et al.  Bipolar affective disorders linked to DNA markers on chromosome 11 , 1987, Nature.

[29]  G. Eisenbarth Type I diabetes mellitus. A chronic autoimmune disease. , 1986 .

[30]  L. Thomas The Lives of a Cell: Notes of a Biology Watcher , 1974 .

[31]  L Roberts Genome mapping goal now in reach. , 1989, Science.

[32]  W. Vollmer,et al.  Survival with dialysis and transplantation in patients with end-stage renal disease. , 1983, The New England journal of medicine.